Field triage for endovascular stroke therapy: a population-based comparison

J Neurointerv Surg. 2020 Mar;12(3):233-239. doi: 10.1136/neurintsurg-2019-015033. Epub 2019 Sep 4.

Abstract

Background: Endovascular therapy (EVT) for stroke improves outcomes but is time sensitive.

Objective: To compare times to treatment and outcomes between patients taken to the closest primary stroke center (PSC) with those triaged in the field to a more distant comprehensive stroke center (CSC).

Methods: During the study, a portion of our region allowed field triage of patients who met severity criteria to a more distant CSC than the closest PSC. The remaining patients were transported to the closest PSC. We compared times to treatment and clinical outcomes between those two groups. Additionally, we performed a matched-pairs analysis of patients from both groups on stroke severity and distance to CSC.

Results: Over 2 years, 232 patients met inclusion criteria and were closest from the field to a PSC; 144 were taken to the closest PSC and 88 to the more distant CSC. The median additional transport time to the CSC was 7 min. Times from scene departure to alteplase and arterial puncture were faster in the direct group (50 vs 62 min; 93 vs 152 min; p<0.001 for both). Among patients who were independent before the stroke, the OR for less disability in the direct group was 1.47 (95% CI 1.13 to 1.93, p=0.003), and 2.06 (95% CI 1.10 to 3.89, p=0.01) for the matched pairs.

Conclusions: In a densely populated setting, for patients with stroke who are EVT candidates and closest to a PSC from the field, triage to a slightly more distant CSC is associated with faster time to EVT, no delay to alteplase, and less disability at 90 days.

Keywords: stroke; thrombectomy.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Endovascular Procedures / methods*
  • Endovascular Procedures / trends
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Male
  • Massachusetts / epidemiology
  • Middle Aged
  • Population Surveillance / methods*
  • Prospective Studies
  • Rhode Island / epidemiology
  • Stroke / diagnosis
  • Stroke / epidemiology*
  • Stroke / therapy*
  • Thrombolytic Therapy / methods
  • Thrombolytic Therapy / trends
  • Time-to-Treatment* / trends
  • Tissue Plasminogen Activator / therapeutic use
  • Triage / methods*
  • Triage / trends

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator